NovaGenix Insights

The Relationship Between Testosterone Therapy and Cancer: What You Need to Know Is Testosterone Replacement Therapy Safe? Exploring Cancer Concerns and Findings Testosterone Replacement Therapy (TRT) has become an increasingly popular treatment for men experiencing symptoms of low testosterone, such as decreased libido , fatigue, and muscle loss. However, concerns about the potential link between TRT and cancer, particularly prostate cancer, have been a topic of debate for many years. This article looks at the relationship between testosterone therapy and cancer, examining the current understanding, historical context, and the importance of regular monitoring and personalized treatment approaches. Historical Concerns About Testosterone and Cancer The historical concern that testosterone therapy might increase the risk of prostate cancer stems from early studies suggesting that testosterone can stimulate the growth of prostate tissue. This led to the belief that higher levels of ...

Managing Hematocrit Levels on Testosterone Replacement Therapy (TRT): What You Need to Know   What Should My Hematocrit Levels be on TRT? When it comes to maintaining hematocrit levels on TRT, understanding the balance is crucial. However, discussing hematocrit and TRT often involves navigating a complex landscape. The normal range of hematocrit levels varies based on factors such as age and gender. In adults, men typically range between 40-50%, whereas for women, it’s generally lower, around 35-44%. Striking the right balance in these levels is essential to avoid potential health risks such as stroke and blood clots. It can be measured using a    CBC   in a routine blood test. Interestingly, elite athletes like Lance Armstrong once used EPO, a medication to boost endurance and red blood cell production. This performance-enhancing method drew intense scrutiny, especially regarding hematocrit levels during competitions. Armstrong's reported hematocrit levels a...